Synthestech Member
  • Member since Oct 30th 2017
  • Last Activity:

Posts by Synthestech

    Dear Max,

    Thank you for your message and information.

    I’d like to inform you that the attempt to connect Mr. Kuroshov with the Syntestech project is a mistake. He is not connected with our project. The direction of research of Synthestech is not based on the biotransmutation. However we believe, that transmutation in biological systems is possible.

    We would like not to give any avaluation of Mr. Kurashov’s speech and conclusions

    Best regards,


    Synthestech"during cold nuclear transmutation a ..conglomerate forms from nucleons of many nuclei

    which breaks down into nuclei of the greatest possible stability; other words possessing no radioactivity."

    This corroborates Mizuno's 1996 statement where he speculates on palladium plus deuterium forming 'medium nuclei"which then break down into more stable nuclei. In some reactions he postulates positron emission i.e conversion of a proton to a neutron,

    Mizuno rationalises his observations of a myriad of transmuted products formed from the Pd/Pt and deuterium both heavier and lighter than palladium..including Osmium, Lead and Mercury and especially lots of Xenon.

    I cannot speak for Vladislav, but as I see it, it is some analog of muon catalysis. I think that Bazhutov’s erzion catalysis interpretation is the closest. It is a particle that is bounded with hydrogen. Energy that is required to unbound it is very small, but once it is unbound it strarts nuclear reactions until it is bounded again with hydrogen or oxygen. To unbound particle from oxygen is a much more difficult goal, requiring plasma or high temperature. Collecting erzion particle in solution might be a very interesting yet simple way to intensify outcome of elements.

    Synthestech so you are planning to raise funds via ICO for the 'unpromising' bio tech with unlikely successful result in 10+ years or is there some other tech you plan to develop?

    Thank you for the question,

    It is completely different method. We worked with impulses and plasma electrolysis of different type of fluids. We came to certain methods, but I personally think that the method itself is just one side, the fluid composition is more important, as well as engineering in terms of producing reliable reactor, that can work for weeks and months.


    Are you planning to offer, for general sale, commercial quantities of isotopes in the foreseeable future? If so, roughly when and will there be a cost advantage over present methods of production?

    Thank you for your question.

    At this stage, it is very difficult to estimate, but in field of isotopes production, we are sure to be able to find market niche.

    In the field of obtaining platinum group all depends on results of further reaserch. Scaling is also a subject for reaserch.

    Welcome Roman.

    Are you planning to publish much detail about your work? You know the saying 'extraordinary claims require extraordinary proof'. Also, have you had much (or any) contact with Vladimir Vyssotski, who has been working in this field for many years?

    Thank you Alan,

    We are preparing details, There will be some experimental data in our White Paper, but we are focused mostly on model of commercial cooperation with investors.

    I don’t think that our claims are extraordinary, there are many researchers who observed transmutation. The only difference is that we were focused on obtaining valuable element in our experiments, while others tried to measure excess energy, radiation etc. This goal is very tightly bounded with analytical chemistry.

    Our know-hows are all about quantity of obtained transmutated elements and engineering solutions.

    I'd like to emphasize that, we are conducting ICO in order to continue research and transform phenomena observed in our experiment into technology.

    We believe, that transmutation of elements is key to commercialization of LENR.

    We dont have any contacts with Vladimir Vyssotski, but plenty of contacts with other researchers. We consider microbiological way unpromising.